Articles tagged "Kidney transplantation"

2018 American Transplant Congress
Reducing Discards for Deceased Kidney Donors over Age 50 by Restricting Biopsy Criteria
C. Hostetler, J. Rogge, B. Nicely, S. Rudich.
Clinical Division, Gift of Life Michigan, Ann Arbor, MI.
The placement of kidneys from deceased organ donors of advanced age is an ongoing challenge. An Organ Procurement Organization (OPO) evaluated its discard rate for…
2018 American Transplant Congress
Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient
P. Brown, D. Venkat.
Henry Ford Hospital, Detroit.
Objective: Limited real world data exists regarding the use of direct acting antivirals (DAA) for HCV viremia in renal transplant patients, particularly those with marked…
2018 American Transplant Congress
Impact of Cigarette Smoking on Living Kidney Donor
Y. Yoon,¹ H. Lee,² J. Na,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.³
¹Urology, Hanyang University College of Medicine, Seoul, Korea; ²Urology, National Health Insurance Service Ilsan Hospital, Goyang, Korea; ³Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea; ⁴Transplantation Surgery, Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea.
Introduction: Smoking is known to result in the decline of renal allograft function and survival of recipients. However, effect of smoking on living kidney donor…
2018 American Transplant Congress
Laparoscopic Donor Nephrectomy Safety: Experience of 500 Cases in Hispanic Population at a Single Institution
Y. Baez Suarez, F. Giron Luque, J. Amaya Nieto.
Transplantation Surgery, Colombiana de Trasplantes, Bogota, Colombia.
Background: Laparoscopic live donor nephrectomy (LDN) has become the best option in living donation because its safety and low rate of complications. This report aims…
2018 American Transplant Congress
Pre-Transplant Assessment of AMR Risk by Novel Donor/recipient Non-HLA Variants
S. Pineda,¹ T. Sigdel,¹ J. Chen,¹ A. Jackson,² M. Sirota,¹ M. Sarwal.¹
¹UCSF, San Francisco; ²Johns Hopkins University, Baltimore.
Transplant (tx) injury from antibody mediated (AMR) and T cell mediated (CMR) rejection, limits indefinite survival after HLA mismatched organ tx. AMR is incompletely diagnosed…
2018 American Transplant Congress
Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era
K. Lentine, D. Axelrod,² R. Bloom,³ H. Xiao,¹ D. Segev,⁴ T. Alhamad,⁵ H. Randall,¹ R. Ouseph,¹ V. Dharnidharka,⁵ D. Brennan,⁴ N. Lam,⁶ A. Naik,⁷ G. Hess,⁸ B. Kaiske,⁹ M. Schnitzler.¹
¹Saint Louis U, St. Louis; ²Lahey, Burlington; ³U Penn, Philadelphia; ⁴Johns Hopkins, Baltimore; ⁵Washington U, St. Louis; ⁶U Alberta, Edmonton, Canada; ⁷U Michigan, Ann Arbor; ⁸Hennepin, Minneapolis; ⁹Symphony Health, Conshohocken.
Hepatitis C virus (HCV) infection in kidney transplant (KTx) donors or recipients has correlated with adverse outcomes, partly due to limited treatment options. Development of…
2018 American Transplant Congress
IgA Recurrence in a Single Center with a Protocol Biopsy Program
M. Merzkani, N. Lepori, M. El Ters, F. Cosio, H. Amer.
Mayo Clinic, Rochester, MN.
The objective of this study was to determine the rate of recurrence of IgA nephropathy in our program aided by protocol biopsies and protocol driven…
2018 American Transplant Congress
Risk Factors for Chronic Opioid Use after Kidney Transplantation
J. Fleming, D. Taber, R. Gilbert, L. Wilson, Z. Elmaasarani, B. O'Brien, N. Patel, N. Pilch, S. Ball, P. Mauldin, P. Baliga.
MUSC, Charleston, SC.
Opioid use is associated with increased complications, graft loss, and mortality in the kidney transplant (KTX) population. The aim of our study was to identify…
2018 American Transplant Congress
Development and Validation of a Socioeconomic Kidney Transplant Derailers Index (KTDI)
J. Peipert,^1,2 J. Beaumont,² M. Robbins,³ A. Paiva,³ C. Anderson,¹ A. Waterman.^1,2
¹UCLA, Los Angeles, CA; ²Terasaki Research Institute, Los Angeles, CA; ³Univ. of Rhode Island, Kingston, RI.
Transplant evaluation requires an assessment of socioeconomic challenges patients face that may derail them from obtaining a kidney transplant (KT). We developed and validated a…
2018 American Transplant Congress
QPI-1002, a siRNA Targeting p53: Improvement in Outcomes Following Acute Kidney Injury (AKI): Cardiac Surgery to AKI Donors
J. Tchervenkov,² E. Squiers,¹ R. Stratta,³ D. Odenheimer,² D. Rothenstein,² QPI-1002 DGF Study Group.
¹Quark Pharmaceuticals, Fremont; ²McGill University Health, Montreal, Canada; ³Wake Forest School of Medicine Centre, Winston-Salem.
Background: QPI-1002 has been observed to statistically reduce the incidence, severity and duration of AKI in a large Phase 2 study of AKI following cardiac…